Delivery Order SPE2DB22D1002-SPE2DB25FLHS0
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The Dexcom G7 is a continuous glucose monitoring system used for diabetes management, aligning with the company's extensive portfolio of...
- The Defense Logistics Agency awarded a delivery order valued at $4,981.76 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The order will be fulfilled from the vendor's...
- The Defense Logistics Agency awarded a $1,525.72 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 28, 2025, with completion scheduled for August 29, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $1 billion through December 2026. The work will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a $1,546.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's substantial role as a critical supplier of medical devices and pharmaceutical products...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,062.40 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 5, 2025, with a completion date of August 6, 2025. The contract utilizes firm fixed pricing and was competitively awarded without set-aside provisions. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The Dexcom G7 is a continuous glucose monitoring...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,062.40 for Dexcom G7 sensors on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger pharmaceutical supply agreements with DLA. The sensors will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. Dexcom G7 is a continuous glucose monitoring system...
- The Defense Logistics Agency awarded a $14,958.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of July 21, 2025. This non-set-aside contract was competitively awarded on July 18, 2025, with performance taking place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The Dexcom G7 is a continuous glucose monitoring system used for diabetes management within military and federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,135.84 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 25, 2025, with completion scheduled for August 26, 2025. The contract utilizes firm fixed pricing and was awarded without a set-aside designation through open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor specializing in pharmaceutical products...
- The Defense Logistics Agency awarded a delivery order valued at $1,846.70 to AmerisourceBergen Drug Corp for Dexcom G7 Sensors on August 20, 2025. This non-competitive, firm fixed-price delivery order is set to be completed by August 21, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Dexcom G7 is a continuous glucose monitoring system used for diabetes management, reflecting the federal government's procurement needs for advanced medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price contract represents a non-competitive, non-set-aside award for continuous glucose monitoring devices to support federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLHS0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,610.79 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on September 15, 2025, with completion targeted for September 16, 2025. This is a firm fixed price delivery order issued under a competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The Dexcom G7 is a continuous glucose monitoring system used for diabetes management and represents part of the broader medical supply portfolio that AmerisourceBergen provides to federal healthcare systems. This delivery order is issued as a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive pharmaceutical and medical supply vehicle supporting military healthcare programs globally. AmerisourceBergen's federal contracting activity demonstrates significant capability in meeting competitive procurement requirements across diverse medical commodities, including specialty medications, vaccines, and medical devices that support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/15/25 |